CB vs STRO
Chubb Ltd (CB) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CB and STRO stock pages for the full models.
Not investment advice.